Changes in Type 2 Diabetes Medication Utilization and Costs in the United States, 2014–2019-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Changes in Type 2 Diabetes Medication Utilization and Costs in the United States, 2014–2019

Published:2021-06-29 Issue:9 Volume:59 Page:789-794
ISSN:0025-7079
Container-title:Medical Care
language:en
Short-container-title:

Author:

Neilson Lynn M.,Munshi Kiraat D.,Peasah Samuel K.,Huang Yan,Swart Elizabeth C.S.,Henderson Rochelle,Manolis Chronis,Good Chester B.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Public Health, Environmental and Occupational Health

Reference16 articles.

1. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes—2021;Diabetes Care,2021

2. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm—2020 Executive Summary;Garber;Endocr Pract,2020

3. Association between use of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 agonists, and dipeptidyl peptidase 4 inhibitors with all-cause mortality in patients with type 2 diabetes: a systematic review and meta-analysis;Zheng;JAMA,2018

4. Comparison of the effects of glucagon-like peptide receptor agonists and sodium-glucose cotransporter 2 inhibitors for prevention of major adverse cardiovascular and renal outcomes in type 2 diabetes mellitus;Zelniker;Circulation,2019

5. Management of hypoglycemia in older adults with type 2 diabetes;Freeman;Postgrad Med,2019

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of diabetes distress among type 2 diabetes mellitus patients in India: a systematic review and meta-analysis;Health Psychology and Behavioral Medicine;2024-03-05

2. Impact of Glucagon-Like Peptide 1 Agonist Deprescription in Type 2 Diabetes in a Real-World Setting: A Propensity Score Matched Cohort Study;Diabetes Therapy;2024-02-29

3. Direct Medical Costs and Medication Use Trends in Patients Having Type 2 Diabetes with Chronic Kidney Disease in Beijing, China in 2016–2018;2024-02-13

4. Impact of the COVID-19 Pandemic on Medical Expenditures Among Medicare Fee-for-Service Beneficiaries Aged ≥67 Years With Diabetes;Diabetes Care;2024-01-16

5. Effect of Glucagon-Like Peptide-1 Deprescription Following Nutrition Therapy via Telemedicine on Glycemia and Body Weight among People with Type 2 Diabetes in a Real-World Setting: A Propensity Score Matched Cohort Study;2023-06-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3